首页> 中文期刊> 《药学学报:英文版》 >Letter to the editor: Anti-RAS drugs and SARS-Co V-2 infection

Letter to the editor: Anti-RAS drugs and SARS-Co V-2 infection

         

摘要

To the Editor:Coronavirus disease 2019(COVID-19)caused by severe acute respiratory syndrome coronavirus 2(SARS-Co V-2)has spread rapidly throughout the world.It has already posed a great threat to global public health security.Angiotensin-converting enzyme 2(ACE2)has been identified as the major receptor of SARS-Co V-2.

著录项

  • 来源
    《药学学报:英文版》 |2020年第7期|P.1251-1252|共2页
  • 作者单位

    Department of Pharmacy Peking University Third Hospital Beijing 100083 ChinaDepartment of Cardiology and Institute of Vascular Medicine Peking University Third Hospital Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides Ministry of Health Key Laboratory of Molecular Cardiovascular Sciences Ministry of Education Beijing Key Laboratory of Cardiovascular Receptors Research Beijing 100083 China;

    Department of Pharmacy Peking University Third Hospital Beijing 100083 China;

    Department of Pharmacy Peking University Third Hospital Beijing 100083 China;

    Department of Pharmacy Peking University Third Hospital Beijing 100083 ChinaDepartment of Cardiology and Institute of Vascular Medicine Peking University Third Hospital Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides Ministry of Health Key Laboratory of Molecular Cardiovascular Sciences Ministry of Education Beijing Key Laboratory of Cardiovascular Receptors Research Beijing 100083 China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 医学微生物学(病原细菌学、病原微生物学);
  • 关键词

    ACE2; drugs; SARS;

    机译:ACE2;毒品;SARS;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号